JFG
UTHR icon

Jefferies Financial Group’s United Therapeutics UTHR Stock Holding History

Jefferies Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$2.3M – 1888
2024
Q1 		$2.3M Buy
+10,000
New +$2.26M 0.02% 543

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jefferies Financial Group's UTHR Position: Q1 2026 in Review

Jefferies Financial Group reduced its United Therapeutics (UTHR) stake by 34% in Q1 2026, selling an estimated $1.57M and leaving 6,001 shares worth $3.56M. The position accounts for 0.02% of the portfolio, ranked #423.

Jefferies Financial Group first reported a position in UTHR in Q1 2023 and has held it in 6 quarters since. The position peaked at $4.46M in Q4 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Jefferies Financial Group held 6,001 shares of United Therapeutics worth $3.56M as of Q1 2026.
  • Jefferies Financial Group sold 3,148 United Therapeutics shares in Q1 2026, an estimated $1.57M.
  • United Therapeutics made up 0.02% of Jefferies Financial Group's portfolio in Q1 2026, its #423 holding.
  • Jefferies Financial Group first reported a position in United Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • Jefferies Financial Group's United Therapeutics position peaked at $4.46M in Q4 2025.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.